Company Prometheus Biosciences, Inc.
Equities
RXDX
US74349U1088
Biotechnology & Medical Research
Business description: Prometheus Biosciences, Inc.
Number of employees: 97
Sales by Activity: Prometheus Biosciences, Inc.
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
Therapeutics | - | 1.12M | 1.23M | 3.13M | 6.81M |
Diagnostic Services | - | 22.67M | - | - | - |
Geographical breakdown of sales: Prometheus Biosciences, Inc.
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
United States | - | 23.79M | 1.23M | 3.13M | 6.81M |
Managers: Prometheus Biosciences, Inc.
Director | Title | Age | Since |
---|---|---|---|
Rita Karachun
CEO | Chief Executive Officer | 62 | 2023-06-15 |
Olivier Laurent
CTO | Chief Tech/Sci/R&D Officer | 53 | 2020-08-31 |
Allison Luo
CTO | Chief Tech/Sci/R&D Officer | 51 | 2018-07-31 |
Vika Brough
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | - | 2021-01-31 |
Members of the board: Prometheus Biosciences, Inc.
Manager | Title | Age | Since |
---|---|---|---|
Rita Karachun
BRD | Director/Board Member | 62 | 2023-06-15 |
Jon Filderman
BRD | Director/Board Member | - | 2023-06-15 |
Company details: Prometheus Biosciences, Inc.

Other Biotechnology & Medical Research
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
-1.50% | +3.75% | +38.33% | -3.02% | 47.96B | ||
-0.87% | +3.37% | -2.89% | -15.36% | 36.65B | ||
-0.77% | -0.06% | +5.35% | +24.92% | 26.22B | ||
-1.27% | -2.82% | -28.10% | -27.88% | 15.97B | ||
-1.71% | -0.99% | +64.98% | +74.02% | 15.52B | ||
-3.01% | -17.30% | -67.17% | -79.66% | 12.55B | ||
-2.93% | -1.01% | +9.72% | -29.43% | 11.51B | ||
-1.90% | +1.42% | +14.68% | +106.42% | 10.98B | ||
+6.11% | +20.16% | - | - | 10.86B | ||
Average | -1.23% | +1.11% | +4.36% | +6.25% | 20.91B | |
Weighted average by Cap. | -1.20% | +1.72% | +10.50% | +2.71% |